Should You Buy 10X Genomics Inc (TXG) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast TXG stock price to fall
10 Analyst Rating
Wall Street analysts forecast TXG stock price to fall
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 19.810
Low
9
Averages
13
High
18
Current: 19.810
Low
9
Averages
13
High
18
William Blair
Market Perform -> Outperform
upgrade
AI Analysis
2026-03-30
New
Reason
William Blair
Price Target
AI Analysis
2026-03-30
New
upgrade
Market Perform -> Outperform
Reason
William Blair upgraded 10x Genomics to Outperform from Market Perform. The firm is positive on the company's role in enabling the high-resolution biological insights needed to build decision-enabling models and considers that execution and profitability have improved, the analyst tells investors in a research note. William Blair adds that on AI, 10x is well positioned to capitalize on the growing demand for large-scale biological data sets to train AI models.
Stifel
Daniel Arias
Buy
maintain
$20 -> $25
2026-03-02
Reason
Stifel
Daniel Arias
Price Target
$20 -> $25
2026-03-02
maintain
Buy
Reason
Stifel analyst Daniel Arias raised the firm's price target on 10x Genomics to $25 from $20 and keeps a Buy rating on the shares. Following this week's AGBT conference in Florida, the firm tells investors that new product adoption for 10x looks "solid" and the competitive environment looks "favorable" within single cell.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TXG
